These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30045610)

  • 1. Effects of Epidural Steroid Injections on Bone Mineral Density and Bone Turnover Markers in Patients Taking Anti-Osteoporotic Medications.
    Nah SY; Lee JH; Lee JH
    Pain Physician; 2018 Jul; 21(4):E435-E447. PubMed ID: 30045610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low bone mineral density, but not epidural steroid injection, is associated with fracture in postmenopausal women with low back pain.
    Yi Y; Hwang B; Son H; Cheong I
    Pain Physician; 2012; 15(6):441-9. PubMed ID: 23159959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women According to Antiosteoporotic Medication Use.
    Kim YU; Karm MH; Cheong Y; Lee J; Kong YG; Kim SH; Suh JH
    Pain Physician; 2016 Jul; 19(6):389-96. PubMed ID: 27454269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational Study to Evaluate the Effect of Epidural Steroid Injection on Bone Mineral Density and Bone Turnover Markers.
    Jain A; Gupta P; Chaurasia R; Singh M; Pandey S
    Pain Physician; 2020 Sep; 23(5):E517-E524. PubMed ID: 32967402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in bone mineral density in postmenopausal women treated with epidural steroid injections for lower back pain.
    Kang SS; Hwang BM; Son H; Cheong IY; Lee SJ; Chung TY
    Pain Physician; 2012; 15(3):229-36. PubMed ID: 22622907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
    Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
    Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lumbar Epidural Steroid Injections on Osteoporotic Fracture and Bone Mineral Density in Elderly Women with Diabetes Mellitus.
    Kim M; Bak J; Kim S; Son HJ; Kang SS; Hue J; Hwang B; Lee SK
    Pain Res Manag; 2020; 2020():1538029. PubMed ID: 33354267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of medications and epidural steroid injections on fractures in postmenopausal women with osteoporosis.
    Kim M; Yang YH; Son HJ; Huh J; Cheong Y; Kang SS; Hwang B
    Medicine (Baltimore); 2019 Jun; 98(26):e16080. PubMed ID: 31261519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
    Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
    Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of raloxifene hydrochloride on bone mineral density and bone turnover in Kuwaiti postmenopausal women with osteoporosis.
    Abdelazim IA; Abdelrazak KM; Al-Kadi M; Yehia AH; Nusair BM; Faza MA
    Arch Osteoporos; 2014; 9():189. PubMed ID: 25037077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of epidural steroid injection on bone mineral density and markers of bone turnover in postmenopausal women.
    Al-Shoha A; Rao DS; Schilling J; Peterson E; Mandel S
    Spine (Phila Pa 1976); 2012 Dec; 37(25):E1567-71. PubMed ID: 23196966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of time and medications with changes in bone mineral density in the 2 years after critical illness.
    Orford NR; Bailey M; Bellomo R; Pasco JA; Cattigan C; Elderkin T; Brennan-Olsen SL; Cooper DJ; Kotowicz MA
    Crit Care; 2017 Mar; 21(1):69. PubMed ID: 28327171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
    Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
    Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
    Papapoulos S; Lippuner K; Roux C; Lin CJ; Kendler DL; Lewiecki EM; Brandi ML; Czerwiński E; Franek E; Lakatos P; Mautalen C; Minisola S; Reginster JY; Jensen S; Daizadeh NS; Wang A; Gavin M; Libanati C; Wagman RB; Bone HG
    Osteoporos Int; 2015 Dec; 26(12):2773-83. PubMed ID: 26202488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.
    Hong AR; Kim JH; Lee KH; Kim TY; Im SA; Kim TY; Moon HG; Han WS; Noh DY; Kim SW; Shin CS
    Osteoporos Int; 2017 Apr; 28(4):1413-1422. PubMed ID: 28083668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.